Cargando…
CD8(+) T cells specific for conserved coronavirus epitopes correlate with milder disease in patients with COVID-19
A central feature of the SARS-CoV-2 pandemic is that some individuals become severely ill or die, whereas others have only a mild disease course or are asymptomatic. Here, we report the development of an improved multimeric αβ T cell staining reagent platform, with each maxi-ferritin “spheromer” dis...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975171/ https://www.ncbi.nlm.nih.gov/pubmed/34210785 http://dx.doi.org/10.1126/sciimmunol.abg5669 |
Sumario: | A central feature of the SARS-CoV-2 pandemic is that some individuals become severely ill or die, whereas others have only a mild disease course or are asymptomatic. Here, we report the development of an improved multimeric αβ T cell staining reagent platform, with each maxi-ferritin “spheromer” displaying 12 peptide-MHC complexes. Spheromers stain specific T cells more efficiently than peptide-MHC tetramers and capture a broader portion of the sequence repertoire for a given peptide-MHC. Analyzing the response in unexposed individuals, we find that T cells recognizing peptides conserved among coronaviruses are more abundant and tend to have a “memory” phenotype compared with those unique to SARS-CoV-2. Notably, CD8(+) T cells with these conserved specificities are much more abundant in patients with mild COVID-19 versus those with a more severe illness, suggesting a protective role. |
---|